HSD11B1: 11-beta-hydroxysteroid dehydrogenase 1
Controls the reversible conversion of biologically active glucocorticoids such as cortisone to cortisol, and 11- dehydrocorticosterone to corticosterone in the presence of NADP(H).
- Drugs that act on it: 5
- Approved: 0
- In phases 1 to 3: 5
- Sponsors: 5
Who is on it, and how far along
Every drug ChEMBL records acting on HSD11B1, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 5
Sponsors
Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.
| ABT-384 | Phase 2 | AbbVie | Small molecule | Inhibitor | 0 |
| AZD-4017 | Phase 2 | AstraZeneca Pharmaceuticals | Small molecule | Inhibitor | 0 |
| BI-187004 | Phase 2 | Boehringer Ingelheim Pharmaceuticals | Small molecule | Inhibitor | 0 |
| BMS-823778 free base | Phase 2 | Bristol-Myers Squibb | Small molecule | Inhibitor | 0 |
| MK-0736 | Phase 2 | Merck & Co. (MSD) | Small molecule | Inhibitor | 0 |
- Cortisone reductase deficiency0.57
- Gastroesophageal reflux disease0.50
- Peptic ulcer disease0.50
- Digestive system disorder0.27
- Knee pain0.24
- Type 2 diabetes mellitus0.14
- Exstrophy-epispadias complex0.12
- Obesity disorder0.11
- Hypertensive disorder0.10
- Metabolic syndrome0.10
- Obesity due to melanocortin 4 receptor deficiency0.10
- Neoplasm0.10
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4235, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. Gene name, function (UniProt P28845, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets